close

Fenwick Represents Accelecare in Investment and Majority Equity Interest from Yukon Partners

December 27, 2013

​Fenwick & West LLP represented Accelecare Wound Centers, a comprehensive wound care and disease management company, in its subordinated debt and equity investment from Yukon Partners. Revelstoke Capital Partners sponsored the transaction in which it, Yukon and seven other institutional co-investors acquired a majority equity interest in Accelecare. Subordinated debt financing was provided by Yukon, The Northwestern Mutual Life Insurance Company, and Nationwide Mutual Insurance Company. The senior credit facility was Agented and underwritten by Ally Commercial Finance. Ally received commitments from Fifth Third Bank and Siemens Financial Services, Inc. to round out the senior financing.

Bain Capital Ventures, SV Life Sciences, River Cities Capital Fund, and management will continue to own a meaningful portion of Accelecare.

The Fenwick transaction team included corporate attorneys Alan Smith, Scott Joachim, Kee Kim, Ashley Walter, Patrick Grilli and Ryan McRobert; executive compensation and employee benefits attorney Scott Spector; technology transactions attorneys Mark Ostrau and Sophia Chen; and tax attorney William Skinner.​